Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation, migration and invasion by depending on p53’s transcriptional activity

Biochemical and Biophysical Research Communications

Volumn 478, Issue 1, 2016, Pages 323-329

  Sun, Lin ^a   Li, Yu ^a   Yang, Bangxiang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Breast cancer; Long non coding RNA; MEG3; p21; p53; Transcriptional activity

Indexed keywords

CD82 ANTIGEN; LONG UNTRANSLATED RNA; MASPIN; MATERNALLY EXPRESSED GENE 3; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG; MEG3 NON-CODING RNA, HUMAN; TP53 PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER CELL; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TRANSCRIPTION INITIATION; TUMOR GENE; BREAST TUMOR; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; TUMOR CELL CULTURE; TUMOR INVASION;

BREAST NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; RNA, LONG NONCODING; TRANSCRIPTIONAL ACTIVATION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84980343859     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.05.031     Document Type: Article

References (25)

1. [1] Polyak, K., Heterogeneity in breast cancer. J. Clin. Investig., 2011, 3786–3788.
2. [2] Perou, C.M., Sørlie, T., Eisen, M.B., van de Rijin, M., Jeffrey, S.S., Rees, C.A., Pollack, J.R., Ross, D.T., Johnsen, H., Akslen, L.A., Fluge, O., Pergamenschikov, A., Williams, C., Zhu, S.X., Lønning, P.E., Børresen-Dale, A.L., Brown, P.O., Botstein, D., Molecular portraits of human breast tumours. Nature, 2000, 747–752.
3. [3] Sørlie, T., Perou, C.M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Thorsen, T., Quist, H., Matese, J.C., Brown, P.O., Botstein, D., Lønning, P.E., Børresen-Dale, A.L., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U.S.A, 2001, 10869–10874.
4. [4] Djebali, S., Davis, C.A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., Tanzer, A., Lagarde, J., Lin, W., Schlesinger, F., Xue, C., Marinov, G.K., Khatun, J., Landscape of transcription in human cells. Nature, 2012, 101–108.
5. [5] Reiche, K., Kasack, K., Schreiber, S., Lüders, T., Due, E.U., Naume, B., Riis, M., Kristensen, V.N., Horn, F., Børresen-Dale, A.L., Hackermüller, J., Baumbusch, L.O., Long non-coding RNAs differentially expressed between normal versus primary breast tumor tissues disclose converse changes to breast cancer-related protein-coding genes. PLoS One, 2014, e106076.
6. [6] Nagano, T., Fraser, P., Emerging similarities in epigenetic gene silencing by long noncoding RNAs. Mamm. Genome, 2009, 557–562.
7. [7] Clark, M.B., Mattick, J.S., Long noncoding RNAs in cell biology. Sem Cell Dev Biol, 2011, 366–376.
8. [8] Mercer, T.R., Dinger, M.E., Mattick, J.S., Long non-coding RNAs: insights into functions. Mat. Rev. Genet., 2009, 155–159.
9. [9] Guttman, M., Rinn, J.L., Modular regulatory principles of large non-coding RNAs. Nature, 2012, 339–346.
10. [10] Gupta, R.A., Shah, N., Wang, K.C., Kim, J., Horlings, H.M., Wong, D.J., Tsai, M.C., Hung, T., Argani, P., Rinn, J.L., Wang, Y., Brzoska, P., Kong, B., Li, R., West, R.B., van de Vijver, M.J., Sukumar, S., Chang, H.Y., Nature, 2010, 1071–1076.
11. [11] Redis, R.S., Sieuwerts, A.M., Look, M.P., Tudoran, O., Ivan, C., Spizzo, R., Zhang, X., de Weerd, V., Shimizu, M., Ling, H., Buiga, R., Pop, V., Irimie, A., Fodde, R., Bedrosian, I., Martens, J.W., Foekens, J.A., Berindan-Neagoe, I., Calin, G.A., Oncotarget, 2013, 1748–1762.
12. [12] Mourtada-Maarabouni, M., Pickard, M.R., Hedge, V.L., Farzaneh, F., Williams, G.T., GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene, 2009, 195–208.
13. [13] Zhao, Z.Y., Chen, C.J., Liu, Y., Wu, C.F., 17β-Estradiol treatment inhibits breast cell proliferation, migration and invasion by decreasing MALAT-1 RNA level. Biochem. Biophys. Res. Commun., 2014, 388–393.
14. [14] Miyoshi, N., Wagatsuma, H., Wakana, S., Shiroishi, T., Nomura, M., Aisaka, K., Kohda, T., Surani, M.A., Kaneko-Ishino, T., Ishino, F., Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells, 2000, 211–220.
15. [15] Zhang, X., Zhou, Y., Mehta, K.R., Danila, D.C., Scolavino, S., Johnson, S.R., Klibanski, A., A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J. Clin. Endocrinol. Metab., 2003, 5119–5126.
16. [16] Ying, L., Huang, Y., Chen, H., Wang, Y., Xia, L., Chen, Y., Liu, Y., Qiu, F., Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol. Biosyst., 2013, 407–411.
17. [17] Wang, P., Ren, Z., Sun, P., Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J. Cell Biochem., 2012, 1868–1874.
18. [18] Anwar, S.L., Krech, T., Hasemeier, B., Schipper, E., Schweitzer, N., Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma. PLoS One, 2012, e49462.
19. [19] Zhang, X., Gejman, R., Mahta, A., Zhong, Y., Rice, K.A., Zhou, Y., Cheunsuchon, P., Louis, D.N., Klibanski, A., Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Res., 2010, 2350–2358.
20. [20] Lu, K.H., Li, W., Liu, X.H., Sun, M., Zhang, M.L., Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer, 2013, 461–471.
21. [21] Su, X., Malouf, G.G., Chen, Y., Zhang, J., Yao, H., Valero, V., Weistein, J.N., Spano, J.P., Meric-Bernstam, F., Khayat, D., Esteva, F.J., Comprehensive analysis of long-non-coding RNAs in human breast cancer clinical subtypes. Oncotarget, 2014, 9864–9876.
22. [22] Piao, H.L., Ma, L., Non-coding RNAs as regulators of mammary development of breast cancer. J. Mamary Gland. Biol. Neoplasia, 2012, 33–42.
23. [23] Gupta, R.A., Shah, N., Wang, K.C., Kim, J., Horlings, H.M., Wong, D.J., Tsai, M.C., Hung, T., Argani, P., Rinn, J.L., Wang, Y., Brzoska, P., Kong, B., Li, R., West, R.B., van de Vijver, M.J., Sukumar, S., Chang, H.Y., Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature, 2010, 1071–1076.
24. [24] Vousden, K.H., Prives, C., Blinded by the light: the growing complexity of p53. Cell, 2009, 413–431.
25. [25] Laptenko, O., Beckrman, R., Freulich, E., Prives, C., p53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation. Proc. Natl. Acad. Sci. U.S.A, 2011, 10385–10390.